DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 4.18% to $16.05 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.30% to 19,735.12 and the Dow Jones Industrial Average rising 0.69% to 45,014.04.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed $45.85 short of its 52-week high ($61.90), which the company achieved on July 31st.
The stock underperformed when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.43% to $4.84, Fortress Biotech Inc. (FBIO) fell 0.46% to $2.18, and Viking Therapeutics Inc. $(VKTX)$ rose 1.95% to $51.24.
Trading volume (432,987) remained 26,093 below its 50-day average volume of 459,080.
Data source: Dow Jones Market Data, FactSet. Data compiled December 4, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 04, 2024 17:24 ET (22:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments